Today: 7 February 2026
Subscribe
Browse Category

Market Outlook News 21 December 2025 - 23 December 2025

Keppel Ltd Stock (SGX:BN4) in Focus on Dec 23, 2025: Buybacks, Data Centre Deals, Analyst Targets, and 2026 Outlook

Keppel Ltd Stock (SGX:BN4) in Focus on Dec 23, 2025: Buybacks, Data Centre Deals, Analyst Targets, and 2026 Outlook

Keppel Ltd stock (SGX:BN4) is ending 2025 with a very specific kind of momentum: the kind built from steady share buybacks, repeatable asset monetisation, and a strategy that markets increasingly read as “asset-light, recurring-income, value-unlocking Keppel” rather than the legacy conglomerate of years past. Keppel+1 As of Dec 23, 2025 (Singapore time), Keppel’s share price was S$10.30, up 0.98% on the day (as at 14:08), after closing S$10.20 on Dec 22. SG Investors Within the same Dec 23 pricing window, MarketScreener showed Keppel at S$10.31, with a +50.58% move since the start of 2025 and a +1.98% five‑day change, reinforcing
23 December 2025
·····
OCBC Stock (SGX: O39) Outlook on 23 Dec 2025: Share Price Near Record High, Analyst Targets, Dividend Signals and 2026 Risks

OCBC Stock (SGX: O39) Outlook on 23 Dec 2025: Share Price Near Record High, Analyst Targets, Dividend Signals and 2026 Risks

SINGAPORE — December 23, 2025. Oversea-Chinese Banking Corporation Limited (OCBC), Singapore’s second-largest bank by assets, is ending 2025 with its stock hovering just below a fresh all-time high, as investors focus on dividends, capital returns and the bank’s fast-growing wealth franchise—while also keeping an eye on margin pressures in a cooling rate environment. SG Investors+2The Straits Times+2 As of 1:48 p.m. Singapore time on Dec. 23, OCBC shares were last indicated around S$19.91, up about 0.45% on the day, with the day’s range roughly S$19.74 to S$19.93. SG Investors+1 That puts OCBC close to the S$19.55 closing level seen on
23 December 2025
·····
Bank of America Stock (NYSE: BAC) Today: Latest News, Analyst Price Targets, and 2026 Outlook (Dec. 22, 2025)

Bank of America Stock (NYSE: BAC) Today: Latest News, Analyst Price Targets, and 2026 Outlook (Dec. 22, 2025)

Bank of America Corporation (NYSE: BAC) opened the holiday-shortened week with its stock pushing near fresh highs, as investors weighed a year-end “Santa rally” in equities against a packed calendar of late-week U.S. economic releases. In intraday trading on Monday, Dec. 22, BAC hovered around $56 per share, putting it close to its 52-week high zone and extending a strong late-2025 run for U.S. money-center banks. Investing.com+1 At the same time, Bank of America itself delivered a headline that is resonating beyond Wall Street: the company announced $10 million in zero‑interest lending to support Los Angeles-area residents and small businesses
22 December 2025
·····
Citigroup Stock Hits a Fresh 52-Week High as Regulators Ease Oversight and Wall Street Updates 2026 Outlook

Citigroup Stock Hits a Fresh 52-Week High as Regulators Ease Oversight and Wall Street Updates 2026 Outlook

Dec. 22, 2025 — Citigroup Inc. (NYSE: C) is ending the year with momentum. In Monday trading, Citigroup stock pushed to a new 52‑week high and traded around $118, extending a powerful 2025 rally that has been driven by a mix of turnaround execution, capital return, and—most recently—regulatory overhang starting to lift. Investing.com+1 For investors trying to separate signal from noise, today’s Citi story is less about a single headline and more about a cluster of developments that collectively support the “simplification + risk-control repair + returns” thesis CEO Jane Fraser has been selling for years—now with outside validation from
22 December 2025
·····
GSK plc Stock: Today’s News, Analyst Forecasts, and the Biggest Catalysts Heading Into 2026 (Dec. 22, 2025)

GSK plc Stock: Today’s News, Analyst Forecasts, and the Biggest Catalysts Heading Into 2026 (Dec. 22, 2025)

As of December 22, 2025, GSK plc (LSE: GSK / NYSE: GSK) is getting an unusually dense cluster of “headline risk + catalyst potential” — the kind of mix that can make a defensive pharma stock trade like it just drank three espressos. In the last two weeks alone, investors have had to price in: Below is the most complete, publication-ready breakdown of current GSK stock news, forecasts, and analyst takes available as of today, plus what to watch next. GSK stock price check On the NYSE, GSK’s American Depositary Shares (ADS) last traded around $48.61. (Each GSK ADS represents
22 December 2025
·····
Yangzijiang Shipbuilding (SGX: BS6) Stock: Latest Price, News, Analyst Forecasts and 2026 Outlook (Dec 22, 2025)

Yangzijiang Shipbuilding (SGX: BS6) Stock: Latest Price, News, Analyst Forecasts and 2026 Outlook (Dec 22, 2025)

Yangzijiang Shipbuilding (Holdings) Ltd (SGX: BS6) started the week on the front foot, rebounding after a late-week pullback and putting the spotlight back on the group’s massive order book, “green vessel” mix, and a debate that refuses to die: is the stock still cheap for what it’s building—and when it’s delivering? As of Dec 22, 2025 (14:39 SGT), BS6 traded at S$3.45, up S$0.08 (+2.37%), with ~6.49 million shares traded and an intraday range of S$3.39 to S$3.45. SG Investors+1That puts the stock within about 3.6% of its 52-week high (S$3.58)—and up roughly 92% from the 52-week low (S$1.80). SG
22 December 2025
······
Healthcare Stocks Outlook (Dec. 21, 2025): Drug-Price Deals, ACA Premium Shock, and 2026 Catalysts Investors Are Watching

Healthcare Stocks Outlook (Dec. 21, 2025): Drug-Price Deals, ACA Premium Shock, and 2026 Catalysts Investors Are Watching

Sunday, December 21, 2025 — With U.S. markets heading into a holiday-shortened final trading stretch, healthcare stocks are back in focus as investors weigh a year-end “Santa rally” against a fast-moving policy backdrop that is unusually direct for the sector: drugmakers cutting prices through White House deals, insurers staring down a subsidy cliff tied to the Affordable Care Act (ACA), and a new wave of biotech dealmaking and capital-markets activity that is reopening risk appetite. Reuters+4Reuters+4The Washington Post+4 Below is a comprehensive roundup of the key healthcare stock news, forecasts, and sector analyses circulating on December 21, 2025, along with
21 December 2025
···
CoreWeave Stock (NASDAQ: CRWV): Latest News, Analyst Forecasts, and 2026 Outlook as of December 21, 2025

CoreWeave Stock (NASDAQ: CRWV): Latest News, Analyst Forecasts, and 2026 Outlook as of December 21, 2025

CoreWeave, Inc. (NASDAQ: CRWV) has become one of the most watched—and most debated—AI infrastructure stocks of 2025. As of December 21, 2025 (a Sunday, with U.S. markets closed), CoreWeave shares are sitting near $83, after a sharp late-week rebound that followed weeks of volatility and “AI bubble” hand-wringing across Wall Street. The timing matters: the stock’s latest surge didn’t come from a single earnings print. Instead, it arrived at the intersection of (1) new/renewed bullish coverage from Wall Street, (2) fresh credibility signals from government and NVIDIA, and (3) investor anxiety about leverage, customer concentration, and data-center execution risk—the “boring”
21 December 2025
·····
Lam Research Stock Week Ahead (LRCX): Analysts Lift Targets as AI Chip Spending Outlook Brightens Into a Holiday-Shortened Market

Lam Research Stock Week Ahead (LRCX): Analysts Lift Targets as AI Chip Spending Outlook Brightens Into a Holiday-Shortened Market

Week ahead: Dec. 22–26, 2025 (report written Dec. 21, 2025) Lam Research Corporation (NASDAQ: LRCX) is heading into the Christmas week on a surge of optimism that has pushed the semiconductor equipment maker to fresh highs—powered by bullish analyst notes, strong AI-driven demand signals from the chip ecosystem, and improving expectations for 2026 capital spending. The catch for traders: next week’s calendar is short and liquidity can be thin, which can magnify both breakouts and pullbacks. Below is a detailed, news-driven look at what’s moving Lam Research stock right now—and what matters most in the coming week. Where Lam Research
21 December 2025
·····
Amazon Stock AMZN Week Ahead Outlook for Dec 22–26 2025: OpenAI Talks, AWS AI Chip Momentum, and a Holiday-Shortened Market

Amazon Stock AMZN Week Ahead Outlook for Dec 22–26 2025: OpenAI Talks, AWS AI Chip Momentum, and a Holiday-Shortened Market

Amazon.com Inc. enters the week of December 22–26, 2025 with investors balancing two forces that often collide at year-end: a thinly traded holiday market and an unusually dense stream of AI-driven headlines that keep Amazon stock (NASDAQ: AMZN) in focus. Shares last traded around the $227 area heading into Sunday, after finishing Friday, December 19 at $227.35. StockAnalysis That puts AMZN in a familiar late-2025 range—close enough to recent highs to keep bulls engaged, but still far enough from the year’s peak to leave room for “catch-up” narratives into 2026. This week-ahead report (dated 21.12.2025) breaks down what matters most
21 December 2025
·····
Software and Platform Stocks Week Ahead: AI Spending Scrutiny, Cloud Security Mega-Deals, and Holiday-Shortened Trading (Dec. 22–26, 2025)

Software and Platform Stocks Week Ahead: AI Spending Scrutiny, Cloud Security Mega-Deals, and Holiday-Shortened Trading (Dec. 22–26, 2025)

Dec. 21, 2025 — Software and platform stocks head into the Christmas week balancing two powerful forces: a thinner, holiday-shortened market that can amplify price swings, and a still-evolving narrative around the AI buildout—specifically, when massive infrastructure spending turns into measurable profits. By Friday’s close, investors were once again talking about a potential “Santa Claus rally,” but the setup feels different than in a typical year. The sector’s winners are increasingly defined by platform leverage (cloud ecosystems, cybersecurity suites, and data/AI tooling) rather than simple “growth at any price.” At the same time, several high-growth SaaS names face tougher comparisons
21 December 2025
···········
Cybersecurity Stocks Week Ahead: Palo Alto Networks, CrowdStrike, Fortinet, Zscaler and Okta in Focus (Dec. 22–26, 2025)

Cybersecurity Stocks Week Ahead: Palo Alto Networks, CrowdStrike, Fortinet, Zscaler and Okta in Focus (Dec. 22–26, 2025)

The final full stretch of 2025 trading arrives with a familiar contradiction: holiday-shortened markets, but no shortage of cybersecurity catalysts. With U.S. stock markets scheduled to close early on Wednesday, Dec. 24 (1:00 p.m. ET) and remain closed on Thursday, Dec. 25, liquidity is expected to thin out—often amplifying single-headline moves in high-momentum groups like cybersecurity. Nasdaq+2New York Stock Exchange+2 For investors tracking cybersecurity stocks into year-end, the biggest themes from Dec. 19–21, 2025 were clear: Below is a week-ahead playbook built from the news, forecasts and analyst framing published Dec. 19–21, 2025, plus the key calendar items that could shape risk appetite into Christmas week. Market setup for the week
21 December 2025
·········
1 2 3 4 5 6 … 26

Stock Market Today

BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Go toTop